From bench to bedside: bipolar androgen therapy in a pilot clinical study

• 来源期刊: 亚洲男性学杂志（英文版）
• 年，卷（期）: 2015,（5）
• 页码范围: 767-768
• 页数: 2页
• 语种: 中文
• DOI: 10.4103/1008-682X.151390

摘要

Prostate cancer remains a leading cause of cancer death in Europe and the United States and is an emerging problem in Asia despite significant improvements in available treatments over the last few decades.Androgen deprivation therapy (ADT) has been the core treatment of advance-staged disease since the discovery of prostate cancer's androgen dependence in 1941 by Huggins et al.